Germany’s Merck KGaA has agreed to collaborate with Mammoth Biosciences on development, scale-up and commercial production of the US biotech’s CRISPR-based SARS CoV-2...

In its biggest pharma acquisition since the 2006 takeover of Berlin-based women’s specialist Schering, Bayer plans to plunk down up to $4 billion for US biotech firm...

Swiss pharma Roche has agreed to collaborate with US biotech Dyno Therapeutics to develop adeno-associated virus (AAV) vectors for gene therapies for central nervous...

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

Specialty pharma company Covis has agreed to buy US-based Amag Pharmaceuticals, boosting its portfolio of therapies for life-threatening conditions and chronic illnesses...